Cutaneous T-cell lymphoma presenting as benign dermatoses.

Area of Science:

• Oncology
• Dermatology
• Immunology

Background:

• Cutaneous T-cell lymphoma (CTCL), also known as mycosis fungoides, is a malignancy affecting T helper (CD4+) cells.
• Early-stage CTCL presents diagnostic challenges as it mimics common benign skin disorders like eczema, psoriasis, and contact dermatitis.
• Histological identification of CTCL can be difficult, often necessitating multiple biopsies for confirmation.

Purpose of the Study:

• To elucidate the diagnostic complexities of cutaneous T-cell lymphoma.
• To outline the prognostic factors influencing patient outcomes in CTCL.
• To describe the immunological consequences and primary causes of mortality in CTCL patients.

Main Methods:

• Review of clinical presentation and diagnostic criteria for CTCL.
• Analysis of histological findings and biopsy requirements.
• Evaluation of treatment modalities, including topical and systemic agents.
• Assessment of prognostic indicators based on disease extent (limited vs. extracutaneous).

Main Results:

• Delayed diagnosis is common due to overlapping symptoms with benign dermatoses.
• Histopathological confirmation may require serial biopsies.
• Prognosis is favorable for limited skin disease but poorer with extracutaneous involvement.
• Disease progression leads to T-cell depletion and significant immunosuppression.

Conclusions:

• Cutaneous T-cell lymphoma presents significant diagnostic and histological challenges.
• Effective management often involves a combination of topical and systemic therapies.
• Infection is the leading cause of mortality in immunosuppressed CTCL patients, particularly those with advanced disease.